Ask a Pharmacist

An exit strategy for opioid therapy

January 26, 2012

What exit strategy do you recommend for discontinuing opioid therapy?
 

Impact of CYP3A4 pathway

January 26, 2012

How does the CYP3A4 pathway impact metabolism of the new oral targeted agents in oncology?
 

Case of the Month

Communication Challenges

Should informed consent mean the patient understands?

January 30, 2012

The patient understood that surgery was the best next step in her treatment. Or, did she?
 

Work-around: An indirect way to accomplish the same goal

December 19, 2011

Interpersonal relations are comparable to navigating computer software. A change in approach may produce the desired results.
 

From Cancer Care

Caring for the caregiver

December 19, 2011

The person who provides care and support at home is an integral part of a patient's care. Nurses need to check on them, too.
 

The importance of cultural competence

Helen H. Miller, LCSW October 19, 2011

A bevy of tools are available to help oncology nurses improve their understanding of patients' cultures.
 

Issues in Cancer Survivorship

Beads of Courage: a lifeline of illness and recovery on a string

January 03, 2012

Tiny works of art are stringed together to tell a child's story of courage during the course of treatment for cancer or another serious illness.
 

Incentive spirometer inspires 
a video game that encourages 
recovery in pediatric patients

December 19, 2011

An incentive spirometer was the inspiration for a video game to help young cancer patients rebuild lung function.
 

Radiation and Your Patient

How to keep radiation therapy safe for patients

, Bryant Furlow December 19, 2011

Radiotherapy, like all medical treatments, has its risks. This discussion reviews the safety issues for patients and nurses.
 

Guidelines reflect changes in radiotherapy for bone metastases

October 19, 2011

New ASTRO guidelines for palliative radiotherapy for bone metastases reflect the results of a meta-analysis of 45 studies.
 

Reflections

Seeing the forest for the trees

Robin Wachsman, RN, BSN, OCN, CCRN October 19, 2011

The search for the cause of a patient's fatigue and shortness of breath reminded a nurse to remember the little details in the big picture.
 

Our pal Joey

Anne Riffenburgh, LCSW March 17, 2011

A young boy is determined to get the answers to questions about his father's radiation treatments, and the treatment team is happy to oblige.
 

Stat Consult

Asparaginase Erwinia chrysanthemi (Erwinaze)

January 26, 2012

Asparaginase Erwinia chrysanthemi is a component of a multiagent regimen for the treatment of acute lymphoblastic leukemia in patients with a hypersensitivity to Escherichia coli-derived asparaginase.
 

Brentuximab vedotin (Adcetris)

December 19, 2011

Brentuximab vedotin is an antibody-drug conjugate comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E.
 

The Patient's Voice

Prostate cancer on the cusp of change

August 01, 2010

The author reflects on enrolling in a clinical trial comparing active surveillance with immediate intervention in men with favorable-risk prostate cancer.
 

Dancing Cancer

Linda McDonald June 15, 2010

The author describes the children's book she wrote to make it easier to talk to children about cancer.
 

The Total Patient

Delicious hospital food: It's not an oxymoron anymore

January 11, 2012

Room service and other high-end dietary experiences are improving overall care at many cancer centers.
 

Exploring holistic medicine: Using acupuncture to relieve cancer-related fatigue

December 19, 2011

The ancient Eastern medicinal art can relieve one of the most distressing effects of cancer and cancer treatment: fatigue.
 

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions